We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.18%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPCB
15976
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
-1,548,384
Closed -$15.6M
ESM.WS
15977
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
-30,835
Closed -$3.59K
WPCA
15978
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
-751,657
Closed -$7.59M
ESM
15979
DELISTED
ESM Acquisition Corporation
ESM
-733,700
Closed -$7.4M
FCRD
15980
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
-76,222
Closed -$325K
HERA
15981
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
-625,000
Closed -$6.33M
FPAC
15982
CALL
DELISTED
Far Peak Acquisition Corporation
FPAC
-189,900
Closed -$1.91M
FPAC
15983
DELISTED
Far Peak Acquisition Corporation
FPAC
-2,631,497
Closed -$26.4M
FPAC
15984
PUT
DELISTED
Far Peak Acquisition Corporation
FPAC
-162,700
Closed -$1.63M
LOKM
15985
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
-150,086
Closed -$1.51M
CNCE
15986
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-79,600
Closed -$465K
CNCE
15987
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-1,391,302
Closed -$8.13M
CNCE
15988
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-400
Closed -$2.34K
RUBY
15989
DELISTED
Rubius Therapeutics, Inc
RUBY
-132,322
Closed -$22.8K
RUBY
15990
PUT
DELISTED
Rubius Therapeutics, Inc
RUBY
-600
Closed -$103
CAJ
15991
CALL
DELISTED
Canon, Inc.
CAJ
-10,100
Closed -$219K
CAJ
15992
PUT
DELISTED
Canon, Inc.
CAJ
-1,300
Closed -$28.2K
FTEV
15993
DELISTED
FinTech Evolution Acquisition Group
FTEV
-749,306
Closed -$7.57M
IONM
15994
DELISTED
Assure Holdings Corp. Common Stock
IONM
-44
Closed -$4.14K
DBS
15995
DELISTED
Invesco DB Silver Fund
DBS
-72,926
Closed -$2.37M
OIIM
15996
DELISTED
02Micro International
OIIM
-54,728
Closed -$245K
ALBO
15997
CALL
DELISTED
Albireo Pharma Inc
ALBO
-25,500
Closed -$551K
ALBO
15998
DELISTED
Albireo Pharma Inc
ALBO
-2,169
Closed -$46.9K
ALBO
15999
PUT
DELISTED
Albireo Pharma Inc
ALBO
-15,600
Closed -$337K
OPNT
16000
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
-14,169
Closed -$287K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.